Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

M.D. Anderson Cancer Center · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
malignant-melanomamelanomaunresectable
The goal of the first phase of this clinical research study is to find the highest tolerable dose of decitabine and peginterferon alfa-2b that can be given in combination to patients with melanoma. The safety of this drug combination will also be studied. The goals of the second phase are to learn if decitabine and peginterferon alfa-2b combined can help to control melanoma, and to find out which doses are more effective and/or better tolerated.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1353133
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive